GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Acorda Therapeutics, Inc. (ACOR) [hlAlert]

Rating:
Buy ACOR
down 4.66 %

Acorda Therapeutics, Inc. (ACOR) rated Buy with price target $34 by Stifel Nicolaus

Posted on: Thursday,  Mar 15, 2012  8:25 AM ET by Stifel Nicolaus

Stifel Nicolaus rated Buy Acorda Therapeutics, Inc. (NASDAQ: ACOR) on 03/15/2012. Previously Stifel Nicolaus rated Buy Acorda Therapeutics, Inc. (NASDAQ: ACOR) on
09/09/2010., when the stock price was $33.24. Since then, Acorda Therapeutics, Inc. has lost 4.66% as of 01/26/2016's recent price of $31.69.
If you would have followed the previous Stifel Nicolaus's recommendation on ACOR, you would have lost 4.66% of your investment in 1965 days.

Acorda Therapeutics is commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the central nervous system. Acorda currently markets Zanaflex Capsules for the management of spasticity. The Company's lead product candidate, Fampridine-SR, for the improvement of walking ability in persons with multiple sclerosis. It develops therapies that restore neurological function to people with spinal cord injury, multiple sclerosis and related conditions of the nervous system.

Stifel Nicolaus research focuses on all market caps, but is a leader in small- and mid-cap research. The department is staffed predominately with industry professionals from outside Wall Street. In fact, approximately 50% of its analysts have hands-on work experience in the industry that they research. Stifel Nicolaus believes industry experience, its opportunistic approach, and broad market cap coverage drive excess returns and its award-winning franchise.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/15/2012 8:25 AM Buy
None
26.13 34.00
as of 12/31/2012
1 Week up  0.93 %
1 Month down  -1.38 %
3 Months down  -2.92 %
1 YTD up  4.27 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/9/2010 8:25 AM Buy
None
33.24 39.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy